Maryland · J0885

Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units in Maryland

Maryland Medicare Avg
$5.75
0% below national avg
National Medicare Avg
$5.78
All states combined
Billed Charge (MD)
$37.18
What providers submit
Est. Commercial (MD)
$14.67
National avg: $16.46
Est. Cash / Self-Pay (MD)
$15.72
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

201.1K
Services in MD
98
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Maryland

Provider Medicare Services
Priego, Victor M.D. $5.82 31.0K
Boccia, Ralph M.D. $5.74 27.9K
Trehan, Ram MD $5.68 12.7K
Barr, Frederick M.D. $5.75 11.7K
Sharma, Daya MD $5.79 11.0K
Cross, Patrick MD $5.96 9.6K
Chhabra, Gurdeep $5.76 7.6K

Maryland Pricing in Context

In Maryland, CPT code J0885 (Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units) carries an average Medicare payment of $5.75 — 0% below the national benchmark of $5.78. 98 providers across the state submitted claims for this procedure in 2023, performing 201.1K total services. Individual payments in MD ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Maryland is $37.18, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Maryland sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Drugs (Administered) procedures, the estimated commercial insurance price in Maryland lands near $14.67, with self-pay cash prices typically around $15.72. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units cost in Maryland?

The average Medicare payment for Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units in Maryland is $5.75, which is 0% below the national average of $5.78. Providers in MD typically bill $37.18 for this procedure.

What does Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units cost with insurance in Maryland?

With commercial insurance in Maryland, Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units costs an estimated $14.67. Without insurance, the estimated cash price is $15.72. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units in Maryland?

98 providers in Maryland billed Medicare for Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units in 2023, performing 201.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units cheaper in Maryland than the national average?

Yes — Injection, Epoetin Alfa, (for Non-Esrd Use), 1000 Units costs 0% below the national average in Maryland. The state average Medicare payment is $5.75 compared to $5.78 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial